Tommy Alain

9.0k total citations · 2 hit papers
97 papers, 5.5k citations indexed

About

Tommy Alain is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Tommy Alain has authored 97 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 34 papers in Genetics and 27 papers in Immunology. Recurrent topics in Tommy Alain's work include Virus-based gene therapy research (30 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and RNA and protein synthesis mechanisms (13 papers). Tommy Alain is often cited by papers focused on Virus-based gene therapy research (30 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and RNA and protein synthesis mechanisms (13 papers). Tommy Alain collaborates with scholars based in Canada, United States and United Kingdom. Tommy Alain's co-authors include Nahum Sonenberg, Ola Larsson, Ivan Topisirović, Masahiro Morita, Bruno D. Fonseca, Peter Forsyth, Valentina Gandin, Emmanuel Petroulakis, Tyson E. Graber and Shannon McLaughlan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Tommy Alain

96 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation

2013 614 citations Masahiro Morita, Tommy Alain et al. profile →
mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs

2010 549 citations Ryan J.O. Dowling, Ivan Topisirović et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tommy Alain Canada	38	3.5k	1.2k	892	852	718	97	5.5k
Rui Zhao China	28	4.5k 1.3×	557 0.5×	786 0.9×	410 0.5×	214 0.3×	100	6.3k
Mamie Z. Li United States	28	5.8k 1.7×	966 0.8×	839 0.9×	309 0.4×	908 1.3×	37	7.8k
Isao Oishi Japan	32	3.9k 1.1×	966 0.8×	1.2k 1.3×	682 0.8×	1.0k 1.5×	83	6.1k
Mohammed Adam Canada	19	3.5k 1.0×	1.5k 1.3×	469 0.5×	240 0.3×	529 0.7×	45	5.0k
David W. Melton United Kingdom	45	5.1k 1.4×	1.4k 1.2×	867 1.0×	225 0.3×	409 0.6×	106	6.3k
Yumi Kanegae Japan	36	3.6k 1.0×	1.9k 1.6×	1.2k 1.3×	273 0.3×	768 1.1×	94	5.9k
Søren Warming United States	32	5.1k 1.4×	894 0.8×	1.4k 1.6×	252 0.3×	2.4k 3.3×	49	7.4k
Gloria González‐Aseguinolaza Spain	35	1.9k 0.5×	1.2k 1.0×	865 1.0×	478 0.6×	1.7k 2.4×	151	4.8k
Yasuhiro Ikeda United States	37	1.8k 0.5×	1.5k 1.3×	399 0.4×	531 0.6×	807 1.1×	111	4.1k

Countries citing papers authored by Tommy Alain

Since Specialization

Citations

This map shows the geographic impact of Tommy Alain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tommy Alain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tommy Alain more than expected).

Fields of papers citing papers by Tommy Alain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tommy Alain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tommy Alain. The network helps show where Tommy Alain may publish in the future.

Co-authorship network of co-authors of Tommy Alain

This figure shows the co-authorship network connecting the top 25 collaborators of Tommy Alain. A scholar is included among the top collaborators of Tommy Alain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tommy Alain. Tommy Alain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Gilchrist, Victoria H., et al.. (2025). Ultrasound and Microbubble Mediated Delivery of Virus-Sensitizing Drugs Improves In Vitro Oncolytic Virotherapy Against Breast Cancer Cells. Ultrasound in Medicine & Biology. 51(7). 1124–1133. 4 indexed citations

2.

Choi, Jung‐Hyun, Jun Luo, Niaz Mahmood, et al.. (2024). The 4EHP-mediated translational repression of cGAS impedes the host immune response against DNA viruses. Proceedings of the National Academy of Sciences. 121(48). e2413018121–e2413018121. 1 indexed citations

3.

Prykhozhij, Sergey V., Anna Cordeiro, Kevin Ban, et al.. (2024). Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafish. Leukemia. 38(10). 2115–2126. 1 indexed citations

4.

Hoang, Huy‐Dung, et al.. (2023). High-Pressure Delivery of Oncolytic Viruses via Needle-Free Injection Preserves Therapeutic Activity. Cancers. 15(23). 5655–5655. 1 indexed citations

5.

Nguyen, My-Anh, Huy‐Dung Hoang, Adil Rasheed, et al.. (2022). miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages. Circulation Research. 131(1). 42–58. 42 indexed citations

6.

Ramsay, LeeAnn, et al.. (2021). Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment. Clinical Cancer Research. 27(12). 3432–3442. 63 indexed citations

7.

El‐Sahli, Sara, Andrew Sulaiman, Li Li, et al.. (2021). A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature. Cell Death and Disease. 12(1). 8–8. 35 indexed citations

8.

O’Dwyer, Conor, Sakie Katsumura, Peyman Ghorbani, et al.. (2020). Hepatic Choline Transport Is Inhibited During Fatty Acid–Induced Lipotoxicity and Obesity. Hepatology Communications. 4(6). 876–889. 6 indexed citations

9.

Pearl, Dana, Sakie Katsumura, Mehdi Amiri, et al.. (2020). 4E-BP–Dependent Translational Control of Irf8 Mediates Adipose Tissue Macrophage Inflammatory Response. The Journal of Immunology. 204(9). 2392–2400. 13 indexed citations

10.

Sulaiman, Andrew, Sara El‐Sahli, Li Li, et al.. (2019). Co-targeting Bulk Tumor and CSCs in Clinically Translatable TNBC Patient-Derived Xenografts via Combination Nanotherapy. Molecular Cancer Therapeutics. 18(10). 1755–1764. 21 indexed citations

11.

Chapat, Clément, Seyed Mehdi Jafarnejad, Edna Matta‐Camacho, et al.. (2017). Cap-binding protein 4EHP effects translation silencing by microRNAs. Proceedings of the National Academy of Sciences. 114(21). 5425–5430. 79 indexed citations

12.

Beug, Shawn T., et al.. (2015). Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists. The International Journal of Developmental Biology. 59(1-2-3). 141–147. 18 indexed citations

13.

Gandin, Valentina, Tommy Alain, Masahiro Morita, et al.. (2014). Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale. Journal of Visualized Experiments. 44 indexed citations

14.

Gandin, Valentina, Tommy Alain, Masahiro Morita, et al.. (2014). Polysome Fractionation and Analysis of Mammalian Translatomes on a Genome-wide Scale. Journal of Visualized Experiments. 133 indexed citations

15.

Nehdi, Atef, et al.. (2014). Deficiency in Either 4E-BP1 or 4E-BP2 Augments Innate Antiviral Immune Responses. PLoS ONE. 9(12). e114854–e114854. 18 indexed citations

16.

Alain, Tommy, Masahiro Morita, Bruno D. Fonseca, et al.. (2012). eIF4E/4E-BP Ratio Predicts the Efficacy of mTOR Targeted Therapies. Cancer Research. 72(24). 6468–6476. 120 indexed citations

17.

Fonseca, Bruno D., Tommy Alain, Tian Jiang, et al.. (2011). Pharmacological and Genetic Evaluation of Proposed Roles of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK), Extracellular Signal-regulated Kinase (ERK), and p90RSK in the Control of mTORC1 Protein Signaling by Phorbol Esters. Journal of Biological Chemistry. 286(31). 27111–27122. 37 indexed citations

18.

Alain, Tommy, Franz J. Zemp, Hongyuan Zhou, et al.. (2010). Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin. Cancer Research. 70(2). 598–608. 89 indexed citations

19.

Dowling, Ryan J.O., Ivan Topisirović, Tommy Alain, et al.. (2010). mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs. Science. 328(5982). 1172–1176. 549 indexed citations breakdown →

20.

Zhou, Hongyuan, Tommy Alain, Beichen Sun, et al.. (2007). Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin. Cancer Research. 67(18). 8818–8827. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact